Wall Street Journal : Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.

 

#Business #WallStreet

Dave Ricks is pushing his scientists to find an even more potent anti-obesity treatment. “Lilly’s got a lead, and we plan to exploit that lead.”

Read More  

WSJ.com: US Business  

PAID 

This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.

Leave a Reply

Generated by Feedzy